|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01931 IVD MEDICAL
Nominal 
10.180 -0.220 (-2.115%) | 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | |
| Turnover | 1,269,595 | -6.197% | 1,353,470 | 1,377,314 | 1,176,557 | 1,186,791 |
| Cost of Sales | (990,001) | -3.769% | (1,028,778) | (1,075,774) | (910,134) | (946,902) |
| Gross Profit | 279,594 | -13.889% | 324,692 | 301,540 | 266,423 | 239,889 |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | 2,698 | -- | (6) | (1,648) | (6,981) | 170 | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (6,032) | 53.917% | (3,919) | (12,792) | 345 | 284 | |
| Profit / (Loss) before Taxation | 71,844 | -60.195% | 180,491 | 162,909 | 103,495 | 118,958 | |
| Taxation | (33,518) | -36.669% | (52,925) | (58,907) | (33,794) | (41,597) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 793 | -- | (2,278) | (993) | 11,448 | 1,526 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 39,119 | -68.777% | 125,288 | 103,009 | 81,149 | 78,887 | |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | |
| Net Finance Costs / (Income) | 21,292 | 115.878% | 9,863 | 8,990 | 11,017 | 8,218 |
| Depreciation & Amortisation | 19,504 | -0.904% | 19,682 | 18,216 | 20,016 | 18,784 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/06 | 2023/06 | 2022/06 | 2021/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/06 | 2023/06 | 2022/06 | 2021/06 | |
| EPS (cts) | 2.410 | -74.002% | 9.270 | 7.620 | 6.070 | 5.960 |
| DPS (cts) | 0.000 | -- | 0.000 | 2.732 | 2.372 | 2.219 |
| Dividend Payout Ratio (%) | -- | -- | -- | 35.854% | 39.074% | 37.223% |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 2.138 | -- | 2.505 | 2.364 | 2.243 | 2.142 |
| Remarks: | Real time quote last updated: 11/09/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 39,119 |
| %Change | -68.777% |
| EPS / (LPS) | RMB 0.024 |
| NBV Per Share (¥) | RMB 2.138 |